Can a virtual pharmacy and coaching help smokers quit? new trial tests three options

NCT ID NCT06832085

Recruiting now Disease control Sponsor: Ottawa Heart Institute Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three approved smoking cessation products—nicotine replacement therapy (patch plus gum or lozenge), cytisine, and varenicline—combined with coaching and home delivery from a virtual pharmacy. Researchers will track how well 150 Ontario adults who smoke use these products and whether they quit. The goal is to see if this approach is practical and effective for helping people stop smoking.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nicotine replacement therapy (patch plus gum or lozenge), cytisine, or varenicline
What this could lead to: If successful, this trial could show which smoking cessation product works best when combined with coaching and home delivery, helping more people quit smoking.
What could go wrong: This is a small vanguard study (150 participants) testing feasibility, not a large definitive trial. Results may not apply to all smokers, and side effects from the medications are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOBACCO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nicotine dependence Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOBACCO

Contacts and locations

Locations

University of Ottawa Heart Institute
RECRUITING

Ottawa, Ontario, K1Y 4W7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.